Cheng Luo
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 67
- Cancer-related gene regulation 52
- Protein Degradation and Inhibitors 49
- Ubiquitin and proteasome pathways 36
- RNA modifications and cancer 25
- Histone Deacetylase Inhibitors Research 24
- Cancer Research top 1%
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods 25
- Organic Chemistry top 1%
- Cell Biology top 1%
-
- Multiple Myeloma Research and Treatments 22
- Co-authors
- Hualiang JiangSarah SpiegelNitai C. HaitZhongjie LiangJeremy C. AllegoodSheldon MilstienKaixian ChenJunyan Lu
- Journals
- Journal of Medicinal Chemistry (37 papers)European Journal of Medicinal Chemistry (20 papers)Bioorganic & Medicinal Chemistry Letters (20 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Cheng Luo
445 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Molecular Biology 8.4k
- Cancer Research 1.2k
- Computational Theory and Mathematics 988
- Organic Chemistry 1.4k
- Cell Biology 770
Countries citing papers authored by Cheng Luo
This map shows the geographic impact of Cheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Luo more than expected).
Fields of papers citing papers by Cheng Luo
This network shows the impact of papers produced by Cheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Luo. The network helps show where Cheng Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 14 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 13 | |
| 13 | MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2 | 2021 | 0 |
| 14 | Look and Feel: The Importance of Sensory Feedback in Virtual Product Experience | 2019 | 3 |
| 15 | 2019 | 73 | |
| 16 | 2017 | 36 | |
| 17 | 2017 | 10 | |
| 18 | 2016 | 10 | |
| 19 | 2015 | 69 | |
| 20 | Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphatebreakdown → | 2009 | 802 |
About Cheng Luo
Cheng Luo is a scholar working on Molecular Biology, Cancer Research, Hematology, Oncology and Hepatology, having authored 457 papers that have together received 12.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (67 papers), Cancer-related gene regulation (52 papers), Protein Degradation and Inhibitors (49 papers), Ubiquitin and proteasome pathways (36 papers), RNA modifications and cancer (25 papers), Computational Drug Discovery Methods (25 papers), Histone Deacetylase Inhibitors Research (24 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Molecular Biology (8.4k citations), Cancer Research (1.2k citations), Computational Theory and Mathematics (988 citations), Organic Chemistry (1.4k citations) and Cell Biology (770 citations). Cheng Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hualiang Jiang, Sarah Spiegel, Nitai C. Hait, Zhongjie Liang, Jeremy C. Allegood, Sheldon Milstien, Kaixian Chen, Junyan Lu, Mingyue Zheng and Tomasz Kordula. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, PLoS ONE and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.